2 completed, 1 withdrawn. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Hypokalemia: new trials by email Literature Review of Hypokalemia trials Research Report on Hypokalemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium Cicletanine + magnesium, Cicletanine - Arterial Hypertension, Diabetes | Phase 1 / Phase 2 | Withdrawn | Navitas Pharma | 2024-06-01 | 2026-11-13 | |
| Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics TREATMENT - Gitelman Syndrome | Phase 1 / Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 33 | 2010-02-01 | 2013-12-10 |
| Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism LCI699 - Primary Hyperaldosteronism | Phase 2 | Completed | Novartis | 12 | 2008-06-01 | 2009-08-26 |
Hypertension (2) · Diabetes Mellitus (1) · Gitelman Syndrome (1) · Hyperaldosteronism (1) · Hyponatremia (1) · Metabolic Diseases (1)
Nutritional and Metabolic Diseases (3) · Water-Electrolyte Imbalance (3) · Cardiovascular Diseases (2) · Endocrine System Diseases (2) · Metabolic Diseases (2) · Vascular Diseases (2) · Adrenal Gland Diseases (1) · Adrenocortical Hyperfunction (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Glucose Metabolism Disorders (1) · Kidney Diseases (1) · Male Urogenital Diseases (1)
Eplerenone (1) · Magnesium (1) · Osilodrostat (1) · Therapeutics (1) · cicletanine (1)
Assistance Publique - Hôpitaux de Paris (1) · Navitas Pharma (1) · Novartis (1)
France (2)